Skip to main content
. Author manuscript; available in PMC: 2015 Mar 3.
Published in final edited form as: Chembiochem. 2014 Jan 23;15(4):595–611. doi: 10.1002/cbic.201300723

Figure 3.

Figure 3

Effect of constrained indazole-based 4EGI-1 mimetic on the expression of mTOR. CRL-2813 were treated with DMSO, (E)-4EGI-1 or 1d at final concentration of 50 and 25 μm for a time period of 8 hrs and lysates were immunoblot with antibodies specific to mTOR and β-actin.